FDA 483 - GlaxoSmithKline dba Human Genome Sciences Inc - July 31, 2025
FDA 483 for GlaxoSmithKline dba Human Genome Sciences Inc on July 31, 2025. Product: biologics. Access full analysis and detailed observations.
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA 483 for GlaxoSmithKline dba Human Genome Sciences Inc on July 31, 2025. Product: biologics. Access full analysis and detailed observations.
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
July 31, 2025
Product Type
biologics
ID: cb6d196a-6452-484a-b22a-7c009013e85a
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox